- Serent portfolio company Procurement Partners acquires Hybrent, an e-procurement solution provider
- The transaction yields one of the largest Procure-to-Pay organizations in healthcare
Hybrent, an e-procurement solution provider to ambulatory surgery centers, physician offices, and post-acute providers nationwide, announced it is combining with Procurement Partners, a provider of procure-to-pay (P2P) solutions for post-acute care and senior living communities. The combination of the two companies yields one of the largest Procure-to-Pay organizations in healthcare.
Hybrent helps healthcare organizations lower costs and save time with its easy-to-use purchasing, inventory management, and invoicing software. Joining forces with Procurement Partners unlocks additional cross-sell opportunities while expanding the combined companies’ robust vendor base and tech expertise.
“We are thrilled that such a reputable partner recognized Hybrent’s efforts to help our customers better manage their procurement,” said Ken Tighe, CEO of Hybrent.
Navneet Gosal, CTO & Co-founder of Hybrent added, “We are confident that our future with Procurement Partners will help take what we have created to the next level, and we are excited to deliver even more value to our customers in this next chapter.”
The Procurement Partners platform improves savings through its 100% invoice digitization, removing the need for manual and paper keying. The platform also offers a compliance audit feature, which can help reduce bottom-line vendor spend for its customers.
“We are incredibly excited to welcome Hybrent into the Procurement Partners family and look forward to leveraging their strong product expertise and knowledge of the ambulatory surgery center, physician office, and other healthcare sectors,” said Rusty Zosel, CEO of Procurement Partners. “Our shared values of a strong customer focus and developing best-in-class technology solutions will be the foundations of a great partnership and shared future.”
While the combined company will collaborate on opportunities to improve their customer experience and maximize growth, Hybrent will operate as an independent company and continue to focus on ambulatory surgery centers, physician offices, and post-acute sectors.
The acquisition is backed by Serent Capital, a growth-focused firm that invests in technology and tech-enabled services companies. Terms of the deal were not disclosed.
Read More About Serent’s Healthcare Investments
Disclaimer:
This publication is for informational purposes only, and nothing contained herein constitutes an offer to sell or a solicitation of an offer to buy any interest in any investment vehicle managed by Serent Capital or any company in which Serent Capital or its affiliates have invested. An offer or solicitation will be made only through a final private placement memorandum, subscription agreement and other related documents with respect to a particular investment opportunity and will be subject to the terms and conditions contained in such documents, including the qualifications necessary to become an investor. Serent Capital does not utilize its website to provide investment or other advice, and nothing contained herein constitutes a comprehensive or complete statement of the matters discussed or the law relating thereto. Information provided reflects Serent Capital’s views as of a particular time and are subject to change without notice. You should obtain relevant and specific professional advice before making any investment decision.
Executive endorsements of Serent Capital are for illustrative purposes, designed to attract business development contacts, and should not be construed as a client or investor testimonial of Serent Capital's investment advisory services. All such endorsements are from current or former portfolio company leadership about Serent Capital’s ability to provide services to their companies. Certain executives are also investors in Serent Capital’s investment vehicle(s), and as such, there is an inherent conflict in that those executives have an incentive to provide favorable reviews of Serent Capital’s business practices for the benefit of the investment vehicles that they hold a personal ownership interest in. Serent Capital has not, directly or indirectly, paid any compensation to such individuals for their endorsements.
Certain information on this Website may contain forward-looking statements, which are subject to risks and uncertainties and speak only as of the date on which they are made. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “aim”, “will” or similar expressions are intended to identify forward-looking statements. Serent Capital undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Past performance is not indicative of future results; no representation is being made that any investment or transaction will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided.
